Overview of the 2022 WHO classification of thyroid neoplasms
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
[HTML][HTML] Differentiated thyroid cancer—treatment: state of the art
B Schmidbauer, K Menhart, D Hellwig… - International journal of …, 2017 - mdpi.com
Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has
increased over the last few decades. It derives from follicular thyroid cells. Generally …
increased over the last few decades. It derives from follicular thyroid cells. Generally …
Molecular targets of tyrosine kinase inhibitors in thyroid cancer
P Fallahi, SM Ferrari, MR Galdiero, G Varricchi… - Seminars in cancer …, 2022 - Elsevier
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising
incidence in the past 20 years. Surgery is the primary strategy of therapy for patients with …
incidence in the past 20 years. Surgery is the primary strategy of therapy for patients with …
[HTML][HTML] Novel treatments for anaplastic thyroid carcinoma
SM Ferrari, G Elia, F Ragusa, I Ruffilli, C La Motta… - Gland …, 2020 - ncbi.nlm.nih.gov
Anaplastic thyroid cancer (ATC) is one of the deadliest human cancers and it is less than 2%
of thyroid carcinomas (TCs). The standard treatment of ATC includes surgical debulking …
of thyroid carcinomas (TCs). The standard treatment of ATC includes surgical debulking …
Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
F Panebianco, AV Nikitski, MN Nikiforova… - Cancer …, 2019 - Wiley Online Library
Background Reactivation of telomerase reverse transcriptase (TERT) is an important event
in cancer. Two hotspot mutations in the TERT promoter region, c.‐124C> T (C228T) and c …
in cancer. Two hotspot mutations in the TERT promoter region, c.‐124C> T (C228T) and c …
M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling
JQ Chen, YP Tao, YG Hong, HF Li, ZP Huang, XF Xu… - Cell Cycle, 2021 - Taylor & Francis
ABSTRACT N6-methyladenosine (m6A) modification, the most abundant internal
methylation of eukaryotic RNA transcripts, is critically implicated in RNA processing. There is …
methylation of eukaryotic RNA transcripts, is critically implicated in RNA processing. There is …
[HTML][HTML] Differentiated thyroid carcinoma in pediatric age: genetic and clinical scenario
F Galuppini, F Vianello, S Censi, S Barollo… - Frontiers in …, 2019 - frontiersin.org
Introduction: Follicular-derived differentiated thyroid carcinoma (DTC) is the most common
endocrine and epithelial malignancy in children. The differences in the clinical and …
endocrine and epithelial malignancy in children. The differences in the clinical and …
[HTML][HTML] BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node …
N Fakhruddin, M Jabbour, M Novy, H Tamim… - Scientific reports, 2017 - nature.com
Concordance between mutations in the primary papillary thyroid carcinoma (PTC) and the
paired x lymph node metastasis may elucidate the potential role of molecular targeted …
paired x lymph node metastasis may elucidate the potential role of molecular targeted …
[HTML][HTML] Targeting EML4-ALK gene fusion variant 3 in thyroid cancer
MD Aydemirli, JDH van Eendenburg… - Endocrine-related …, 2021 - erc.bioscientifica.com
Finding targetable gene fusions can expand the limited treatment options in radioactive
iodine-refractory (RAI-r) thyroid cancer. To that end, we established a novel cell line …
iodine-refractory (RAI-r) thyroid cancer. To that end, we established a novel cell line …
[HTML][HTML] Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary …
Purpose To evaluate whether if ultrasonography (US)-based radiomics enables prediction of
the presence of BRAFV600E mutations among patients diagnosed as papillary thyroid …
the presence of BRAFV600E mutations among patients diagnosed as papillary thyroid …